Efficacy and safety of tacrolimus ointment 0·1% vs. betamethasone 17-valerate 0·1% in the treatment of chronic paronychia: an unblinded randomized study-Reference-Cited by-同舟云学术

Efficacy and safety of tacrolimus ointment 0·1% vs. betamethasone 17-valerate 0·1% in the treatment of chronic paronychia: an unblinded randomized study

Published:2009-04 Issue:4 Volume:160 Page:858-860
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:

Author:

Rigopoulos D.,Gregoriou S.,Belyayeva E.,Larios G.,Kontochristopoulos G.,Katsambas A.

Publisher

Wiley

Subject

Dermatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2133.2008.08988.x/fullpdf

Reference17 articles.

1. Chronic paronychia and onycholysis: a thirteen-year experience;Daniel;Cutis,1996

2. Topical steroids versus systemic antifungals in the treatment of chronic paronychia: an open, randomized double-blind and double dummy study;Tosti;J Am Acad Dermatol,2002

3. Assigning new roles to topical tacrolimus;Rallis;Expert Opin Investig Drugs,2007

4. A prospective randomized clinical trial of 0·1% tacrolimus ointment in a model of chronic allergic contact dermatitis;Belsito;J Am Acad Dermatol,2006

5. Topical tacrolimus 0·1% ointment (Protopic) reverses nickel contact dermatitis elicited by allergen challenge to a similar degree to mometasone furoate 0·1% with greater suppression of late erythema;Alomar;Contact Dermatitis,2003

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management;Journal of Clinical Medicine;2024-03-20

2. Cutaneous Fungal Infections in Older Adults;Clinics in Geriatric Medicine;2024-02

3. Omloop/paronychia;Kleine Kwalen in de huisartsenpraktijk;2023-11-14

4. Role of Homoeopathy in Managing Chronic Paronychia: A Pretest–Posttest Interventional Study;Homœopathic Links;2022-12

5. Acute and chronic paronychia revisited: A narrative review;Journal of Cutaneous and Aesthetic Surgery;2022